GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cyclezyme AB (XSAT:CYCLE) » Definitions » Intrinsic Value: Projected FCF

Cyclezyme AB (XSAT:CYCLE) Intrinsic Value: Projected FCF : kr0.00 (As of Jun. 22, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Cyclezyme AB Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-22), Cyclezyme AB's Intrinsic Value: Projected FCF is kr0.00. The stock price of Cyclezyme AB is kr15.30. Therefore, Cyclezyme AB's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Cyclezyme AB's Intrinsic Value: Projected FCF or its related term are showing as below:

XSAT:CYCLE's Price-to-Projected-FCF is not ranked *
in the Chemicals industry.
Industry Median: 1.18
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Cyclezyme AB Intrinsic Value: Projected FCF Historical Data

The historical data trend for Cyclezyme AB's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclezyme AB Intrinsic Value: Projected FCF Chart

Cyclezyme AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
- - - - -

Cyclezyme AB Quarterly Data
Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cyclezyme AB's Intrinsic Value: Projected FCF

For the Specialty Chemicals subindustry, Cyclezyme AB's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyclezyme AB's Price-to-Projected-FCF Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cyclezyme AB's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Cyclezyme AB's Price-to-Projected-FCF falls into.


;
;

Cyclezyme AB Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Cyclezyme AB  (XSAT:CYCLE) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Cyclezyme AB's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=15.30/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyclezyme AB Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Cyclezyme AB's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyclezyme AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, 223 63
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.

Cyclezyme AB Headlines

No Headlines